|
HY-P74734-10ug
|
MedChemexpress LLC
|
NEIL1, Human (His)
|
|
|
|
|
HY-P74734-5ug
|
MedChemexpress LLC
|
NEIL1, Human (His)
|
|
|
|
|
HY-P74734-50ug
|
MedChemexpress LLC
|
NEIL1, Human (His)
|
|
|
|
|
HY-W181102-100mg
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-W181102-50mg
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-W181102-1mL
|
MedChemexpress LLC
|
NFAT Inhibitor-2 [CAS 422546-87-0] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-156214-1mg
|
MedChemexpress LLC
|
NICE-01 [CAS 2982819-94-1]
|
|
|
|
|
HY-156214-10mg
|
MedChemexpress LLC
|
NICE-01 [CAS 2982819-94-1]
|
|
|
|
|
HY-156214-5mg
|
MedChemexpress LLC
|
NICE-01 [CAS 2982819-94-1]
|
|
|
|
|
HY-15925-250mg
|
MedChemexpress LLC
|
Nitro blue tetrazolium chloride [CAS 298-83-9]
|
|
|
|
|
HY-15925-500mg
|
MedChemexpress LLC
|
Nitro blue tetrazolium chloride [CAS 298-83-9]
|
|
|
|
|
HY-15925-1mL
|
MedChemexpress LLC
|
Nitro blue tetrazolium chloride [CAS 298-83-9] (10mM in DMSO)
|
|
|
|
|
HY-115759-10mg
|
MedChemexpress LLC
|
N-Octylmaleimide [CAS 4080-76-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-115759-100mg
|
MedChemexpress LLC
|
N-Octylmaleimide [CAS 4080-76-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-115759-25mg
|
MedChemexpress LLC
|
N-Octylmaleimide [CAS 4080-76-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-115759-50mg
|
MedChemexpress LLC
|
N-Octylmaleimide [CAS 4080-76-6]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-115759-1mL
|
MedChemexpress LLC
|
N-Octylmaleimide [CAS 4080-76-6] (10mM in DMSO)
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100034-10mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-100mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-2mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-25mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-5mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-50mg
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5]
|
|
Cancer-programmed cell death
|
|
|
HY-100034-1mL
|
MedChemexpress LLC
|
NSC 663284 [CAS 383907-43-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-108543-10mg
|
MedChemexpress LLC
|
NSC 95397 [CAS 93718-83-3]
|
|
Cancer-Kinase/protease
|
|
